Articles related to Pain Medicine

According to the researchers who published their findings in JAMA Network Open, the percentage of chronic pain patients using non-drug therapies without opioids remained relatively stable at 20% from 2011 to 2016, but it then increased quickly, reaching 40% in 2019. Non-opioid therapy is preferred for treating chronic pain, according to CDC guidance. However, neither the use of opioids alone nor in combination with non-drug treatments for chronic pain significantly decreased following the 2016 guidance. In fact, while about 3% to 15% of patients used opioids alone, their use increased slightly between 2016 and 2018 (from about 10% to 15% of patients).

A 5-year-old boy from China who had IgA vasculitis at age 2 presented with progressively painful skin ulcerations on his extremities for the past month. Find the reason behind the skin lesions on this young boy by answering the image challenge.

The controversial 2016 CDC opioid guideline for chronic pain is updated and replaced by the new guidance, which addresses acute, subacute, and chronic pain for primary care and other clinicians. Some organizations misapplied the 2016 guideline, which was perceived as imposing strict opioid dose and duration limits. As a result, the guideline authors clarified their recommendations in 2019.

Part 1—Pain Management Fundamentals Following completion of this activity (1.0 AMA PRA Category 1 Credit™, 1.0 AANP credit, 1.0 ACPE credit, 1.0 ANCC credit), the participant should be able to: Explain the importance of comprehensive pain education Outline the fundamental concepts of pain management, such as pain definitions and pain mechanisms. Examine patients who are in pain, including identifying risk factors for substance abuse and addiction. Discuss the various pain-management approaches, including nonpharmacologic and pharmacologic (non-opioid and opioid analgesic) therapies.

Misunderstandings and misperceptions about migraine persist, leading to misdiagnosis and less-than-optimal management. In this video, migraine experts seek to update the primary care provider on the current understanding of the disease, and the role of gepants, ditans, triptans, calcitonin gene-related peptide antibodies, and other therapies.

This broad review of recent studies in women’s health topics aims to help the primary care physician in discussing and guiding therapy for women in topics from cardiovascular disease to pelvic pain. The review covers such questions as: How does migraine with aura affect CVD risk in women? How do you respond to patient questions about fracture risk and bisphosphonates? Are antidepressants safe for women who are considering pregnancy? Is gabapentin effective for chronic pelvic pain?